Detalhe da pesquisa
1.
Spatial transcriptomics and the anatomical pathologist: Molecular meets morphology.
Histopathology
; 84(4): 577-586, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991396
2.
Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma.
Histopathology
; 84(7): 1095-1110, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155475
3.
TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
Int J Gynecol Pathol
; 43(2): 111-122, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37406453
4.
Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
Aust N Z J Obstet Gynaecol
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299485
5.
Identifying recurrences and metastasis after ductal carcinoma in situ (DCIS) of the breast.
Histopathology
; 82(1): 106-118, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482277
6.
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
J Pathol
; 256(4): 388-401, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897700
7.
Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials.
Int J Gynecol Cancer
; 33(1): 102-108, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603894
8.
Aurora Kinase A Is an Independent Predictor of Invasive Recurrence in Breast Ductal Carcinoma in situ.
Pathobiology
; 89(6): 382-392, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533650
9.
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.
J Pathol
; 253(1): 41-54, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32901952
10.
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
Mod Pathol
; 34(1): 194-206, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32724153
11.
Options for the Treatment of Mucinous Ovarian Carcinoma.
Curr Treat Options Oncol
; 22(12): 114, 2021 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773517
12.
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.
Br J Cancer
; 122(10): 1496-1506, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32203210
13.
Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei.
BMC Cancer
; 20(1): 369, 2020 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32357859
14.
Therapeutic options for mucinous ovarian carcinoma.
Gynecol Oncol
; 156(3): 552-560, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31902686
15.
Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.
J Pathol
; 248(3): 326-338, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30843206
16.
Molecular comparison of interval and screen-detected breast cancers.
J Pathol
; 248(2): 243-252, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30746706
17.
The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution.
Br J Cancer
; 120(11): 1075-1082, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31065110
18.
Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study.
Mod Pathol
; 32(10): 1473-1485, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175326
19.
Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ.
Mod Pathol
; 32(10): 1460-1472, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175327
20.
Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ.
Mod Pathol
; 32(5): 639-649, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429518